Thomas Jefferson University
OrganisationROR
People
Ph.d., 27 Aug 2026, reporter.nih.gov
27 Aug 2026, reporter.nih.gov
Associate professor, 30 Jun 2026, reporter.nih.gov
30 Jun 2026, reporter.nih.gov
Professor, 26 Jun 2026, reporter.nih.gov
Professor, 18 Jun 2026, reporter.nih.gov
Assistant professor, 22 Jan 2026, reporter.nih.gov
Trials
Phase 2, Recruiting, 2026, 100 people, 20 May 2026, clinicaltrials.gov
A Prolonged Nightly Fasting for Men on ADT for PCa
No phase, Completed, 2024, 40 people, 10 Mar 2026, clinicaltrials.gov
Collaborator, Phase 2, Recruiting, 2026, 496 people, 1 Aug 2025, clinicaltrials.gov
Phase 1/2, Recruiting, 2025, 400 people, 14 Feb 2025, clinicaltrials.gov
Collaborator, Phase 2, Recruiting, 2026, 34 people, 15 Feb 2024, clinicaltrials.gov
Penn Medicine Biobank Return of Results Program
Collaborator, No phase, Active, not recruiting, 2023, 2,500 people, 19 Oct 2023, clinicaltrials.gov
Phase 1, Recruiting, 2023, 24 people, 25 Nov 2022, clinicaltrials.gov
Phase 1, Completed, 2023, 6 people, 3 Oct 2022, clinicaltrials.gov
Phase 1, Terminated, 2022, 4 people, 10 Sept 2022, clinicaltrials.gov
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
Phase 3, Recruiting, 2022, 660 people, 22 Jul 2022, clinicaltrials.gov
Phase 2, Recruiting, 2021, 63 people, 2 Sept 2021, clinicaltrials.gov
Phase 2, Active, not recruiting, 2020, 50 people, 7 Jul 2020, clinicaltrials.gov
Phase 1, Active, not recruiting, 2020, 4 people, 25 Jun 2020, clinicaltrials.gov
Phase 1/2, Withdrawn, 2020, 0 people, 5 Jun 2020, clinicaltrials.gov
Phase 2, Status unknown, 2020, 66 people, 27 Apr 2020, clinicaltrials.gov
Phase 1, Completed, 2022, 8 people, 25 Feb 2020, clinicaltrials.gov
Phase 4, Status unknown, 2020, 76 people, 19 Dec 2019, clinicaltrials.gov
Phase 1, Completed, 2020, 4 people, 10 Dec 2019, clinicaltrials.gov
Phase 2, Suspended, 2017, 5 people, 4 May 2017, clinicaltrials.gov
Phase 1, Completed, 2017, 12 people, 20 Mar 2017, clinicaltrials.gov
Grants and prizes
R21, Epigenetically Preserved iNSCs to Study dsRNA-Mediated Inflammation in C9orf72-ALS/FTD, R21AG101730, US$429k, 2026–2028, 27 Aug 2026, reporter.nih.gov
R34, Assessing the Feasibility of a Remotely-Delivered Tai Chi Intervention for Older GI Cancer Patients Experiencing Chemotherapy-Induced Peripheral Neuropathy, R34CA297502, US$312.4k, 2026–2029, 30 Jun 2026, reporter.nih.gov
R01, Provider Support and Patient Outreach in Lung Cancer Screening, R01CA258849, US$654.9k, 2022–2027, 26 Jun 2026, reporter.nih.gov
National Institute of General Medical Sciences
R35, Molecular Mechanisms of Mitochondrial Transcription and Replication, R35GM131832, US$37k, 2019–2029, 18 Jun 2026, reporter.nih.gov
National Institute of General Medical Sciences
R35, Molecular Mechanisms of Mitochondrial Transcription and Replication, R35GM131832, US$544.2k, 2019–2029, 19 May 2026, reporter.nih.gov
R01, Promoting regenerative repair of aged cartilage, R01AG078609, US$773.8k, 2023–2028, 22 Jan 2026, reporter.nih.gov